Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China

NCT02898922 is registered in ClinicalTrials.gov with Shandong Province Centers for Disease Control and Prevention as lead sponsor.

NCT NCT02898922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02898922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China
Lead sponsor
Shandong Province Centers for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
Not reported
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccines